- Report
- March 2024
- 101 Pages
Asia Pacific
From €3073EUR$3,450USD£2,683GBP
- Report
- March 2024
- 90 Pages
Africa, Middle East
From €3073EUR$3,450USD£2,683GBP
- Report
- March 2024
- 100 Pages
North America
From €3073EUR$3,450USD£2,683GBP
- Report
- March 2024
- 87 Pages
From €3073EUR$3,450USD£2,683GBP
- Report
- March 2024
- 104 Pages
Europe
From €3073EUR$3,450USD£2,683GBP
- Report
- February 2024
- 180 Pages
Global
From €3964EUR$4,450USD£3,460GBP
- Report
- March 2023
- 346 Pages
Global
From €3964EUR$4,450USD£3,460GBP
- Report
- June 2023
- 263 Pages
Global
From €3207EUR$3,600USD£2,799GBP
- Report
- October 2022
- 346 Pages
Global
From €3207EUR$3,600USD£2,799GBP
- Report
- September 2022
- 118 Pages
Middle East, Africa
From €1336EUR$1,500USD£1,166GBP
- Report
- October 2025
- 97 Pages
Saudi Arabia
From €4320EUR$4,850USD£3,771GBP
- Report
- April 2025
- 145 Pages
Global
From €4320EUR$4,850USD£3,771GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$6,001USD£4,508GBP
- Report
- September 2024
- 97 Pages
Global
From €4320EUR$4,850USD£3,771GBP
- Report
- June 2024
- 310 Pages
Global
From €2182EUR$2,450USD£1,905GBP
- Report
- February 2024
- 260 Pages
Global
From €2182EUR$2,450USD£1,905GBP
- Report
- October 2023
- 85 Pages
United States
From €4320EUR$4,850USD£3,771GBP
- Report
- August 2023
- 180 Pages
Global
From €3340EUR$3,750USD£2,916GBP
- Report
- September 2022
Global
€4990EUR$6,001USD£4,508GBP
- Directory
- August 2022
- 1046 Pages
Japan
From €8863EUR$9,950USD£7,737GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more